BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 6, 2006
View Archived Issues
Nuvelo Surges On Alfimeprase Agreement For Up To $385M
Nuvelo Inc.'s stock benefitted Thursday when the company entered a collaboration with pharmaceutical giant Bayer HealthCare AG to develop and commercialize the cardiovascular drug alfimeprase. (BioWorld Today)
Read More
Diversa Cuts Staff, Focuses Efforts On Late-Stage Work
Read More
AVEO In-Licenses Kinase Inhibitor From Mitsubishi
Read More
NeoPharm Raising $35.7M; Pivotal Phase III Goes On
Read More
Innovive Adding Dual Inhibitor To Oncology Pipeline For CML
Read More
Appointments And Advancements
Read More
Other News To Note
Read More